Matches in Wikidata for { <http://www.wikidata.org/entity/Q86586814> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q86586814 description "2014 թվականին հրատարակված գիտական հոդված" @default.
- Q86586814 description "artikull shkencor i botuar më 01 janar 2014" @default.
- Q86586814 description "artículu científicu espublizáu en xineru de 2014" @default.
- Q86586814 description "im Jahr 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86586814 description "scientific article published on 01 January 2014" @default.
- Q86586814 description "wetenschappelijk artikel" @default.
- Q86586814 description "наукова стаття, опублікована в січні 2014" @default.
- Q86586814 description "научна статия" @default.
- Q86586814 name "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 name "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 name "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 type Item @default.
- Q86586814 label "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 label "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 label "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 prefLabel "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 prefLabel "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 prefLabel "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 P1433 Q86586814-D6B1EA48-4FF8-4359-AEDA-2E46988D91AD @default.
- Q86586814 P1476 Q86586814-497C6D97-5AD7-4B35-BDB8-22FF1599A204 @default.
- Q86586814 P2093 Q86586814-20D420FF-794C-46F2-AC28-DAA872054105 @default.
- Q86586814 P2093 Q86586814-2CACEF18-2DD7-4ACC-8E01-5C8A5432E9A0 @default.
- Q86586814 P2093 Q86586814-6691AF48-76F5-4C40-9FCF-E49B0ED0A797 @default.
- Q86586814 P2093 Q86586814-CA71B4EA-A8E1-4F60-BEBA-7CAA1B1BF21B @default.
- Q86586814 P2093 Q86586814-CE9A69A1-6C2A-4EE0-A96F-7E6776A65330 @default.
- Q86586814 P2093 Q86586814-EF20EAB2-FE4C-4ED2-B48B-5B6834706BAE @default.
- Q86586814 P2860 Q86586814-001E7556-A189-4796-9531-7C276EA741E4 @default.
- Q86586814 P2860 Q86586814-187A776D-27A7-4724-AAB6-AF71D65E6DC7 @default.
- Q86586814 P2860 Q86586814-37F43CAD-ADB6-4179-BEAA-AFEA5E2E81C2 @default.
- Q86586814 P2860 Q86586814-44751920-667F-427F-B81C-BB78B9A6BE29 @default.
- Q86586814 P2860 Q86586814-51F8CE2B-5120-495D-A8DD-A4B370064002 @default.
- Q86586814 P2860 Q86586814-550A6194-6FD1-4B3F-A295-22595998BBD4 @default.
- Q86586814 P2860 Q86586814-6EA2E96C-2B1B-4B75-B3D0-0CE4786C1A5D @default.
- Q86586814 P2860 Q86586814-731BE6A8-861C-431E-A1EB-B251FA391B09 @default.
- Q86586814 P2860 Q86586814-8DD1E32B-BA59-41BF-B884-5FC71C2A90E0 @default.
- Q86586814 P2860 Q86586814-AADD161F-9B24-450B-8E1F-584291B8B225 @default.
- Q86586814 P2860 Q86586814-B07D8CA9-3E0D-4009-AC86-4C15C7FF6F00 @default.
- Q86586814 P2860 Q86586814-B79CAF2C-3508-4D62-84E9-594429844B67 @default.
- Q86586814 P2860 Q86586814-EBB61496-54B0-46C2-8CE1-A6B89AF0D716 @default.
- Q86586814 P2860 Q86586814-F0238899-28EB-4BD0-9249-FE14CA188176 @default.
- Q86586814 P304 Q86586814-D017B36A-2CE6-44E2-81AE-DBEB92004A03 @default.
- Q86586814 P31 Q86586814-9207C682-D0C8-4926-8D5C-61DED2FB2EB0 @default.
- Q86586814 P356 Q86586814-71E961F5-2F89-4280-BAAC-010802645015 @default.
- Q86586814 P433 Q86586814-1B35B8C2-EBEA-460D-B773-1ED03E6EFB94 @default.
- Q86586814 P478 Q86586814-242ACF08-24CA-48A1-8629-4C6FE38C8555 @default.
- Q86586814 P577 Q86586814-4990AB12-0C0E-474E-A663-D0DF6FD04AAA @default.
- Q86586814 P698 Q86586814-72F6AE5C-3F2C-4507-9EEA-E43AF6EB709E @default.
- Q86586814 P921 Q86586814-F7553BC0-657D-4EAD-92D4-0B316A78E992 @default.
- Q86586814 P356 S40261-013-0147-0 @default.
- Q86586814 P698 24158940 @default.
- Q86586814 P1433 Q15753215 @default.
- Q86586814 P1476 "Pharmacokinetics, safety and tolerability of DA-6034, an anti-inflammatory agent, after single and multiple oral administrations in healthy volunteers" @default.
- Q86586814 P2093 "In-Jin Jang" @default.
- Q86586814 P2093 "Jae-Yong Chung" @default.
- Q86586814 P2093 "Jieon Lee" @default.
- Q86586814 P2093 "Jung-Ryul Kim" @default.
- Q86586814 P2093 "Kwang-Hee Shin" @default.
- Q86586814 P2093 "Kyoung Soo Lim" @default.
- Q86586814 P2860 Q22242049 @default.
- Q86586814 P2860 Q37420344 @default.
- Q86586814 P2860 Q37727232 @default.
- Q86586814 P2860 Q38094100 @default.
- Q86586814 P2860 Q38679779 @default.
- Q86586814 P2860 Q39533875 @default.
- Q86586814 P2860 Q46789125 @default.
- Q86586814 P2860 Q46815560 @default.
- Q86586814 P2860 Q46874951 @default.
- Q86586814 P2860 Q64461015 @default.
- Q86586814 P2860 Q67282546 @default.
- Q86586814 P2860 Q69911596 @default.
- Q86586814 P2860 Q69933523 @default.
- Q86586814 P2860 Q72999092 @default.
- Q86586814 P304 "37-42" @default.
- Q86586814 P31 Q13442814 @default.
- Q86586814 P356 "10.1007/S40261-013-0147-0" @default.
- Q86586814 P433 "1" @default.
- Q86586814 P478 "34" @default.
- Q86586814 P577 "2014-01-01T00:00:00Z" @default.
- Q86586814 P698 "24158940" @default.
- Q86586814 P921 Q323936 @default.